I agree that this site is using cookies. You can find further informations here.
X
Mo, Dun-chang
434  results:
Search for persons X
?
1

Letter regarding: "Bilateral cochlear implants in a case of..:

Zhu, Xian-Ze ; Mo, Dun-Chang ; Chen, Long
International Journal of Surgery Case Reports.  116 (2024)  - p. 109326 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Severe and fatal adverse events of immune checkpoint inhibi..:

Feng, Yao-Ning ; Xie, Guang-Yu ; Xiao, Li...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Nephrotoxicity of immune checkpoint inhibitor combination t..:

Tan, An-ju ; Mo, Dun-chang ; Wu, Ka...
World Journal of Urology.  41 (2023)  6 - p. 1563-1571 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Distant metastasis-free survival with adjuvant pembrolizuma..:

Mo, Dun-Chang ; Huang, Jian-Feng ; Luo, Peng-Hui..
The Lancet Oncology.  24 (2023)  1 - p. e7 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Combination therapy with immune checkpoint inhibitors in re..:

Chen, Long ; Mo, Dun-Chang ; Hu, Min...
International Immunopharmacology.  119 (2023)  - p. 110270 , 2023
Link: https://doi.org/10.1016/..
 
?
6

PD-1/PD-L1 inhibitor monotherapy in recurrent or metastatic..:

Chen, Long ; Mo, Dun-Chang ; Hu, Min...
American Journal of Otolaryngology.  43 (2022)  2 - p. 103324 , 2022
Link: https://doi.org/10.1016/..
 
?
7

The angiotensin receptor and neprilysin inhibitor, LCZ696, ..:

Chen, Yan ; He, Qian ; Mo, Dun-Chang...
Medicine.  101 (2022)  41 - p. e30904 , 2022
Link: https://doi.org/10.1097/..
 
?
8

PD-1/PD-L1 inhibitor plus chemotherapy versus standard of c..:

Mo, Dun-Chang ; Huang, Jian-Feng ; Luo, Peng-Hui...
European Archives of Oto-Rhino-Laryngology.  280 (2022)  1 - p. 1-9 , 2022
Link: https://doi.org/10.1007/..
 
?
9

Efficacy of immune checkpoint inhibitor as maintenance ther..:

Mo, Dun-Chang ; Huang, Jian-Feng ; Luo, Peng-Hui..
Medicine.  101 (2022)  38 - p. e30830 , 2022
Link: https://doi.org/10.1097/..
 
?
10

The efficacy and safety of combination therapy with immune ..:

Mo, Dun-Chang ; Huang, Jian-Feng ; Luo, Peng-Hui..
International Immunopharmacology.  96 (2021)  - p. 107594 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Combination therapy with immune checkpoint inhibitors in ad..:

Mo, Dun-Chang ; Huang, Jian-Feng ; Luo, Peng-Hui..
Clinical Immunology.  232 (2021)  - p. 108876 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Safety and efficacy of pembrolizumab plus lenvatinib versus..:

Mo, Dun-Chang ; Luo, Peng-Hui ; Huang, Shang-Xiao..
International Immunopharmacology.  91 (2021)  - p. 107281 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Liver and spleen stiffness in predicting the recurrence of ..:

Xiang, Xiao ; Wang, Yang ; Mo, Dun-Chang...
Journal of Hepatology.  70 (2019)  4 - p. 806-807 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Single nucleotide polymorphism of rs2596542 and the risk of..:

Kuang, Xue-Jun ; Mo, Dun-Chang ; Qin, Yan...
Medicine.  98 (2019)  11 - p. e14767 , 2019
Link: https://doi.org/10.1097/..
 
?
15

Systematic review of treatment strategy for recurrent hepat..:

Wang, Hong-Liang ; Mo, Dun-Chang ; Zhong, Jian-Hong...
Medicine.  98 (2019)  8 - p. e14498 , 2019
Link: https://doi.org/10.1097/..
 
1-15